Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$870M |
| 3 |
Amazon
AMZN
|
+$600M |
| 4 |
Meta Platforms (Facebook)
META
|
+$343M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.71% |
| 2 | Healthcare | 16.11% |
| 3 | Consumer Discretionary | 11.47% |
| 4 | Communication Services | 10.62% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Badger Meter
BMI
$3.78B
| $3.03M | ﹤0.01% |
56,500
+800
| +1% | +$48.7K |
|
1202
Capitol Federal Financial
CFFN
$1.08B
| $3.03M | ﹤0.01% |
260,600
+3,400
| +1% | +$43.6K |
|
|
OPLN
1203
Openlane
OPLN
$4.41B
| $3M | ﹤0.01% |
249,800
-5,700
| -2% | -$111K |
|
1204
Kennametal
KMT
$2.38B
| $2.99M | ﹤0.01% |
160,700
+2,800
| +2% | +$79.8K |
|
|
EGOV
1205
DELISTED
NIC Inc
EGOV
| $2.99M | ﹤0.01% |
129,900
+1,700
| +1% | +$34.7K |
|
1206
Dorman Products
DORM
$4.02B
| $2.98M | ﹤0.01% |
54,000
+700
| +1% | +$47.6K |
|
1207
WesBanco
WSBC
$4.09B
| $2.98M | ﹤0.01% |
125,745
| – | – |
|
1208
National Vision
EYE
$1.5B
| $2.98M | ﹤0.01% |
153,400
+5,200
| +4% | +$162K |
|
|
AAN.A
1209
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $2.97M | ﹤0.01% |
130,200
+800
| +0.6% | +$18.2K |
|
|
FIT
1210
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.96M | ﹤0.01% |
445,100
+10,400
| +2% | +$67.2K |
|
1211
Elastic
ESTC
$8.9B
| $2.96M | ﹤0.01% |
53,000
+1,800
| +4% | +$116K |
|
1212
Xencor
XNCR
$1.71B
| $2.96M | ﹤0.01% |
99,000
+1,400
| +1% | +$46.4K |
|
|
CCXI
1213
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.95M | ﹤0.01% |
73,500
+1,100
| +2% | +$46.7K |
|
1214
FormFactor
FORM
$10.1B
| $2.95M | ﹤0.01% |
146,800
+2,800
| +2% | +$66.9K |
|
1215
HUB Group
HUBG
$2.46B
| $2.94M | ﹤0.01% |
129,400
+1,600
| +1% | +$40.1K |
|
1216
Macy's
M
$6.19B
| $2.94M | ﹤0.01% |
599,200
+5,682
| +1% | +$77K |
|
|
BHVN
1217
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.93M | ﹤0.01% |
86,000
+1,200
| +1% | +$54.9K |
|
1218
Horace Mann Educators
HMN
$2.13B
| $2.92M | ﹤0.01% |
79,900
+1,100
| +1% | +$45.4K |
|
1219
Navient
NAVI
$849M
| $2.92M | ﹤0.01% |
385,800
-11,300
| -3% | -$135K |
|
1220
Advanced Drainage Systems
WMS
$11.3B
| $2.92M | ﹤0.01% |
99,300
+3,400
| +4% | +$137K |
|
1221
AutoNation
AN
$6.9B
| $2.91M | ﹤0.01% |
103,800
+1,500
| +1% | +$61.9K |
|
1222
International Bancshares
IBOC
$4.54B
| $2.89M | ﹤0.01% |
107,500
+700
| +0.7% | +$25.1K |
|
1223
Cabot Corp
CBT
$4.51B
| $2.89M | ﹤0.01% |
110,600
| – | – |
|
1224
Insight Enterprises
NSIT
$4.57B
| $2.89M | ﹤0.01% |
68,500
| – | – |
|
|
SAGE
1225
DELISTED
Sage Therapeutics
SAGE
| $2.89M | ﹤0.01% |
100,500
+1,700
| +2% | +$98.4K |
|
Similar funds
Swiss National Bank's Q1 2020 Portfolio in Review
As of Q1 2020, Swiss National Bank held 2,510 positions worth $94.2B, down 3.4% from $97.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Swiss National Bank deployed $18.4B of net new capital in Q1 2020, opening 4 new positions and adding to 1,998 existing holdings. Its largest new stake was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $5.64M trimmed.
- Swiss National Bank's largest Q1 2020 buy was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
- Swiss National Bank added most to Apple in Q1 2020, an estimated $883M increase.
- Swiss National Bank's biggest Q1 2020 reduction was C.H. Robinson, cutting an estimated $5.64M.
- Swiss National Bank fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $52.4M.
- Swiss National Bank's ten largest holdings make up 22% of its $94.2B portfolio in Q1 2020.
- Swiss National Bank opened 4 new positions and closed 30 in Q1 2020.
- Swiss National Bank's portfolio value fell 3.4% quarter-over-quarter to $94.2B.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.